Ardelyx, Inc.

ARDX Healthcare Biotechnology

Ardelyx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $407.3 million, up 22.1% from fiscal 2024. In the quarter to June 2026, revenue grew 23.8%, EPS grew 12.5%, free cash flow grew 75.3% and total debt rose 25.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

3.09 0.18 −5.50%
Market cap
$814.9M
P/E
0.0×
Fwd P/E
−122×
Dividend yield
—
F-score
2/9
Altman Z
1.12
Beneish M
−2.40
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
3.35 3.45 3.44 2.81
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
3,651.82 67.07 (45.68) (197.71)
P/B ratio
8.64 8.42 9.91 8.49
Price to Tangible BV
8.64 8.42 9.91 8.49
EV/Sales
3.31 3.36 3.43 2.80
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(24.60) (32.26) (40.40) (72.87)
EV/FCF
(23.84) (31.16) (39.07) (70.44)
Quick Ratio
3.83 3.80 2.93 2.89
Current Ratio
4.41 4.31 3.49 3.34
Net Debt/EBITDA
(7.28) (10.27) 1.08 2.54
Debt/Assets
41.58% 40.44% 40.34% 43.73%
Debt/Equity
1.31 1.21 1.37 1.69
Asset Turnover
0.93 0.87 0.94 0.86
Operating CF/Net income
(0.38) (51.48) 0.86 0.38
Capex/Depreciation
(0.17) (0.39) (0.08) (0.02)
Interest Coverage
0.58 0.67 (4.74) (2.00)
Research and Development Expense of Revenue
16.38% 18.25% 21.37% 21.59%
Selling, General and Administrative Expense of Revenue
75.78% 69.01% 108.25% 83.92%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
11.55% 9.94% 14.99% 12.67%
Graham Net Nets
0.03 0.03 0.02 0.01
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(4.25%) (4.36%) (3.91%) (4.39%)
Free Cash Flow Yield
(4.15%) (3.13%) (2.55%) (1.42%)
Revenue per Share
0.46 0.52 0.38 0.49
Operating CF per Share
0.00 0.09 (0.13) (0.03)
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
0.00 0.09 (0.13) (0.03)
Cash per Share
1.00 1.10 0.97 1.14
Shareholders Equity per Share
0.64 0.69 0.60 0.60
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.64 0.69 0.60 0.60
Free Cash Flow
0.21 20.59 (32.31) (6.41)
Working Capital
284.60 293.71 272.30 309.71
Capital Expenditures
(0.16) (0.36) (0.07) (0.01)
Net Current Asset Value
36.10 47.66 25.99 15.05
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.00 0.00 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
64.90 64.78 64.65 81.45
Average Payables
17.11 17.62 20.96 30.05
Average Inventory
18.28 19.45 23.26 24.07
Average Assets
427.02 468.68 457.35 521.33
Average Common Equity
156.29 170.12 147.15 144.27

Fold the line items

Columns are period end dates